The authors proposed a mechanism that consists of GATA4 direct binding to NPPA-AS1 as a scaffold for EP300 recruitment, promoting subsequent GATA4 acetylation and pathological cardiac hypertrophy. The gene discussed is NPPA; the disease is cardiac hypertrophy.